Oracle Corporation (FRA:ORC)
171.20
+8.63 (5.31%)
At close: Jan 9, 2026
Oracle Employees
Oracle had 162,000 employees as of May 31, 2025. The number of employees increased by 3,000 or 1.89% compared to the previous year.
Employees
162,000
Change (1Y)
3,000
Growth (1Y)
1.89%
Revenue / Employee
€324,816
Profits / Employee
€82,114
Market Cap
490.35B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 162,000 | 3,000 | 1.89% |
| May 31, 2024 | 159,000 | -5,000 | -3.05% |
| May 31, 2023 | 164,000 | 21,000 | 14.69% |
| May 31, 2022 | 143,000 | 11,000 | 8.33% |
| May 31, 2021 | 132,000 | -3,000 | -2.22% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Oracle News
- 1 day ago - Burry's Oracle Short Bet: Investor cites AI risks and debt; OpenAI deal adds execution pressure - The Times of India
- 1 day ago - Oracle: Now Is The Time To Be Greedy (Rating Upgrade) - Seeking Alpha
- 1 day ago - Michael Burry Takes Bearish Stance on Oracle (ORCL) - GuruFocus
- 1 day ago - "Big Short" investor Michael Burry bets against Oracle - Seeking Alpha
- 2 days ago - Oracle Corporation (ORCL) Announces Retirement of Long-Standing Board Members - GuruFocus
- 2 days ago - Why Oracle Stock Crushed it on Friday - The Motley Fool
- 2 days ago - Oracle announces departure of two oldest directors, narrowing board to 12 - CNBC
- 2 days ago - Oracle and Amazon are AI ‘loser’ stocks — but here’s why that’s primed to change - MarketWatch